University of California San Francisco

Publications

  1. Natural Killer Cell Phenotypes and Clinical Outcomes in Pediatric Kidney Transplantation.
    2024 | PubMed
  2. Gene expression-based molecular scoring of pancreas transplant rejection for a quantitative assessment of rejection severity and resistance to treatment.
    2024 | PubMed
  3. Organ Donation and Transplantation Registries Across the Globe: A Review of the Current State.
    2024 | PubMed
  4. The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts.
    2023 | PubMed
  5. Proteome Analysis for Inflammation Related to Acute and Convalescent Infection.
    2023 | PubMed
  6. Urine trumps the protocol biopsy for subclinical rejection surveillance.
    2023 | PubMed
  7. Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection.
    2023 | PubMed
  8. Plasma proteome perturbation for CMV DNAemia in kidney transplantation.
    2023 | PubMed
  9. Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors.
    2023 | PubMed
  10. Longitudinal serum proteomics analyses identify unique and overlapping host response pathways in Lyme disease and West Nile virus infection.
    2022 | PubMed
  11. Perturbations of the T-cell immune repertoire in kidney transplant rejection.
    2022 | PubMed
  12. Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination.
    2022 | PubMed
  13. The Immune Signatures data resource, a compendium of systems vaccinology datasets.
    2022 | PubMed
  14. Malnutrition and immune cell subsets in children undergoing kidney transplantation.
    2022 | PubMed
  15. A reference tissue atlas for the human kidney.
    2022 | PubMed
  16. Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.
    2022 | PubMed
  17. Through the Looking Glass: Unraveling the Stage-Shift of Acute Rejection in Renal Allografts.
    2022 | PubMed
  18. Urinary Biomarkers for Kidney Allograft Injury.
    2022 | PubMed
  19. Multiplexed droplet single-cell sequencing (Mux-Seq) of normal and transplant kidney.
    2021 | PubMed
  20. FcER1: A Novel Molecule Implicated in the Progression of Human Diabetic Kidney Disease.
    2021 | PubMed
  21. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
    2021 | PubMed
  22. A large staghorn stone diagnosed and managed in an asymptomatic patient using the "Kidney Injury Test (Kit)" spot urine assay: A case report.
    2021 | PubMed
  23. The Importance of Bringing Transplantation Tolerance to the Clinic.
    2021 | PubMed
  24. A Comprehensive Urine Proteome Database Generated From Patients With Various Renal Conditions and Prostate Cancer.
    2021 | PubMed
  25. Rationale and design of the Kidney Precision Medicine Project.
    2021 | PubMed
  26. Use of the Tissue Common Rejection Module Score in Kidney Transplant as an Objective Measure of Allograft Inflammation.
    2021 | PubMed
  27. Corrigendum: Near-Single-Cell Proteomics Profiling of the Proximal Tubular and Glomerulus of the Normal Human Kidney.
    2021 | PubMed
  28. Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation.
    2021 | PubMed
  29. Molecular Diversity of Clinically Stable Human Kidney Allografts.
    2021 | PubMed
  30. A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project.
    2020 | PubMed
  31. Single-cell RNA sequencing of Tocilizumab-treated peripheral blood mononuclear cells as an in vitro model of inflammation.
    2020 | PubMed
  32. Impact of Sarcopenia on Simultaneous Pancreas and Kidney Transplantation Outcomes: A Retrospective Observational Cohort Study.
    2020 | PubMed
  33. Near-Single-Cell Proteomics Profiling of the Proximal Tubular and Glomerulus of the Normal Human Kidney.
    2020 | PubMed
  34. Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantation.
    2020 | PubMed
  35. Peripheral Blood RNA Sequencing Unravels a Differential Signature of Coding and Noncoding Genes by Types of Kidney Allograft Rejection.
    2020 | PubMed
  36. Clinical and Analytical Validation of a Novel Urine-Based Test for the Detection of Allograft Rejection in Renal Transplant Patients.
    2020 | PubMed
  37. Targeted Urine Metabolomics for Monitoring Renal Allograft Injury and Immunosuppression in Pediatric Patients.
    2020 | PubMed
  38. Avoidance of CNI and steroids using belatacept-Results of the Clinical Trials in Organ Transplantation 16 trial.
    2020 | PubMed
  39. A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection.
    2020 | PubMed
  40. Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report.
    2020 | PubMed
  41. Long-term follow-up of beta cell replacement therapy in 10 HIV-infected patients with renal failure secondary to type 1 diabetes mellitus.
    2020 | PubMed
  42. Non-radiological assessment of kidney stones using the kidney injury test (KIT), a spot urine assay.
    2020 | PubMed
  43. Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes.
    2020 | PubMed
  44. Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies.
    2019 | PubMed
  45. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
    2019 | PubMed
  46. A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring.
    2019 | PubMed
  47. A Modified Injector and Sample Acquisition Protocol Can Improve Data Quality and Reduce Inter-Instrument Variability of the Helios Mass Cytometer.
    2019 | PubMed
  48. Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.
    2019 | PubMed
  49. A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury.
    2019 | PubMed
  50. Assessment of Postdonation Outcomes in US Living Kidney Donors Using Publicly Available Data Sets.
    2019 | PubMed
  51. Call for an End to Unethical Transplant Practices: A Concerted Effort by the Transplant Community.
    2019 | PubMed
  52. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.
    2019 | PubMed
  53. Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR.
    2018 | PubMed
  54. The common rejection module in chronic rejection post lung transplantation.
    2018 | PubMed
  55. Urinary Virome Perturbations in Kidney Transplantation.
    2018 | PubMed
  56. Mechanisms and biomarkers of immune quiescence in kidney transplantation.
    2018 | PubMed
  57. Targeted Transcriptional Profiling of Kidney Transplant Biopsies.
    2018 | PubMed
  58. Corrigendum: Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant.
    2018 | PubMed
  59. Discovery of Immune Reactive Human Proteins by High-Density Protein Arrays and Customized Validation of Potential Biomarkers by ELISA.
    2018 | PubMed
  60. LC-SRM-Based Targeted Quantification of Urinary Protein Biomarkers.
    2018 | PubMed
  61. Optimization for Peptide Sample Preparation for Urine Peptidomics.
    2018 | PubMed
  62. Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant.
    2017 | PubMed
  63. Protein biomarkers in renal transplantation.
    2017 | PubMed
  64. Expression of Mitochondrial-Encoded Genes in Blood Differentiate Acute Renal Allograft Rejection.
    2017 | PubMed
  65. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.
    2017 | PubMed
  66. Transplantomics: Toward Precision Medicine in Transplantation Research.
    2017 | PubMed
  67. Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience.
    2017 | PubMed
  68. A Comprehensive Analysis of the Current Status and Unmet Needs in Kidney Transplantation in Southeast Asia.
    2017 | PubMed
  69. Assessment of Circulating Protein Signatures for Kidney Transplantation in Pediatric Recipients.
    2017 | PubMed
  70. Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
    2017 | PubMed
  71. Transplant genetics and genomics.
    2017 | PubMed
  72. Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.
    2017 | PubMed
  73. A combined biomarker and clinical panel for chronic graft versus host disease diagnosis.
    2016 | PubMed
  74. Unraveling the Role of Allo-Antibodies and Transplant Injury.
    2016 | PubMed
  75. Advances in diagnostics for transplant rejection.
    2016 | PubMed
  76. Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated Nephropathy.
    2016 | PubMed
  77. Self-antigens and rejection: a proteomic analysis.
    2016 | PubMed
  78. Mining the human urine proteome for monitoring renal transplant injury.
    2016 | PubMed
  79. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization.
    2016 | PubMed
  80. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
    2016 | PubMed
  81. Non-HLA Antibodies in Clinical Transplantation.
    2016 | PubMed
  82. Circulating CD40 autoantibody and suPAR synergy drives glomerular injury.
    2015 | PubMed
  83. A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts.
    2015 | PubMed
  84. Computational Models for Transplant Biomarker Discovery.
    2015 | PubMed
  85. Transcriptional Perturbations in Graft Rejection.
    2015 | PubMed
  86. Pediatric Deceased Donation-A Report of the Transplantation Society Meeting in Geneva.
    2015 | PubMed
  87. Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management.
    2015 | PubMed
  88. Tolerance associated gene expression following allogeneic hematopoietic cell transplantation.
    2015 | PubMed
  89. Perturbations in the urinary exosome in transplant rejection.
    2015 | PubMed
  90. Mapping novel immunogenic epitopes in IgA nephropathy.
    2014 | PubMed
  91. Antibody-mediated rejection in young kidney transplant recipients: the dilemma of noncompliance and insufficient immunosuppression.
    2014 | PubMed
  92. A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation.
    2014 | PubMed
  93. The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.
    2014 | PubMed
  94. Endothelial cell antibodies associated with novel targets and increased rejection.
    2014 | PubMed
  95. A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.
    2014 | PubMed
  96. Inhibition of intracellular clusterin attenuates cell death in nephropathic cystinosis.
    2014 | PubMed
  97. Transcriptional profiling of belatacept and calcineurin inhibitor therapy in renal allograft recipients.
    2014 | PubMed
  98. Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate.
    2014 | PubMed
  99. Optimization for peptide sample preparation for urine peptidomics.
    2014 | PubMed
  100. Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection.
    2013 | PubMed
  101. The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics.
    2013 | PubMed
  102. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation.
    2013 | PubMed
  103. Quality of life after organ transplantation in children.
    2013 | PubMed
  104. Biologic markers of chronic GVHD.
    2013 | PubMed
  105. Moving beyond HLA: a review of nHLA antibodies in organ transplantation.
    2013 | PubMed
  106. A rapid noninvasive assay for the detection of renal transplant injury.
    2013 | PubMed
  107. Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling.
    2013 | PubMed
  108. Identification of gene microarray expression profiles in patients with chronic graft-versus-host disease following allogeneic hematopoietic cell transplantation.
    2013 | PubMed
  109. Immune response profiling identifies autoantibodies specific to Moyamoya patients.
    2013 | PubMed
  110. The clinical impact of humoral immunity in pediatric renal transplantation.
    2013 | PubMed
  111. Significance and suppression of redundant IL17 responses in acute allograft rejection by bioinformatics based drug repositioning of fenofibrate.
    2013 | PubMed
  112. A common blood gene assay predates clinical and histological rejection in kidney and heart allografts.
    2013 | PubMed
  113. Discovery and customized validation of antibody targets by protein arrays and indirect ELISA.
    2013 | PubMed
  114. The pits and pearls in translating operational tolerance biomarkers into clinical practice.
    2012 | PubMed
  115. A peripheral blood diagnostic test for acute rejection in renal transplantation.
    2012 | PubMed
  116. p62/SQSTM1 prominently accumulates in renal proximal tubules in nephropathic cystinosis.
    2012 | PubMed
  117. Stanniocalcin supports the functional adaptation of adult-sized kidneys transplanted into the pediatric recipients.
    2012 | PubMed
  118. Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up.
    2012 | PubMed
  119. Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation.
    2012 | PubMed
  120. Protein and peptide biomarkers in organ transplantation.
    2012 | PubMed
  121. A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.
    2012 | PubMed
  122. Guidelines for the use and interpretation of assays for monitoring autophagy.
    2012 | PubMed
  123. The bumpy road of genomic medicine in transplantation: lessons from studies on calcineurin inhibitor nephrotoxicity.
    2012 | PubMed
  124. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants.
    2012 | PubMed
  125. A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation.
    2012 | PubMed
  126. Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury.
    2012 | PubMed
  127. Cell-free DNA as a measure of transplant injury.
    2012 | PubMed
  128. Profiling of autoantibodies in IgA nephropathy, an integrative antibiomics approach.
    2011 | PubMed
  129. Recent advances in biomarker discovery in solid organ transplant by proteomics.
    2011 | PubMed
  130. The coin toss of B cells in rejection and tolerance: danger versus defense.
    2011 | PubMed
  131. The dual role of epithelial-to-mesenchymal transition in chronic allograft injury in pediatric renal transplantation.
    2011 | PubMed
  132. Functional proteogenomics--embracing complexity.
    2011 | PubMed
  133. Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes.
    2011 | PubMed
  134. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease.
    2011 | PubMed
  135. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.
    2011 | PubMed
  136. Soluble human leukocyte antigen-G in pediatric renal transplantation.
    2011 | PubMed
  137. Applications of translational bioinformatics in transplantation.
    2011 | PubMed
  138. Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type.
    2011 | PubMed
  139. Biomarkers in solid organ transplantation: establishing personalized transplantation medicine.
    2011 | PubMed
  140. Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients.
    2011 | PubMed
  141. Profiling the proteome in renal transplantation.
    2011 | PubMed
  142. Transplantomics and biomarkers in organ transplantation: a report from the first international conference.
    2011 | PubMed
  143. Organ transplantation after cardiac death.
    2011 | PubMed
  144. Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation.
    2010 | PubMed
  145. Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease.
    2010 | PubMed
  146. Analysis of clinical variables associated with tolerance in pediatric liver transplant recipients.
    2010 | PubMed
  147. Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients.
    2010 | PubMed
  148. Differential immunogenicity and clinical relevance of kidney compartment specific antigens after renal transplantation.
    2010 | PubMed
  149. Harnessing the diversity of the human T-cell repertoire: a monitoring tool for transplantation tolerance?
    2010 | PubMed
  150. Comparison of multiplex meta analysis techniques for understanding the acute rejection of solid organ transplants.
    2010 | PubMed
  151. Abnormal mitochondrial autophagy in nephropathic cystinosis.
    2010 | PubMed
  152. Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis.
    2010 | PubMed
  153. Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions.
    2010 | PubMed
  154. Molecular diagnostics in transplantation.
    2010 | PubMed
  155. Monitoring calcineurin inhibitor therapy: localizing the moving target.
    2010 | PubMed
  156. Steroid minimization for sirolimus-treated renal transplant recipients.
    2010 | PubMed
  157. Pediatric kidney transplantation.
    2010 | PubMed
  158. Pediatric renal transplantation: an overview and update.
    2010 | PubMed
  159. Cell type-specific gene expression differences in complex tissues.
    2010 | PubMed
  160. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation.
    2010 | PubMed
  161. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection.
    2010 | PubMed
  162. The yin and yang of B cells in graft rejection and tolerance.
    2010 | PubMed
  163. Caspase-4 may play a role in loss of proximal tubules and renal injury in nephropathic cystinosis.
    2010 | PubMed
  164. Shotgun proteomics identifies proteins specific for acute renal transplant rejection.
    2010 | PubMed
  165. Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis.
    2009 | PubMed
  166. BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection.
    2009 | PubMed
  167. Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients.
    2009 | PubMed
  168. Balancing efficacy and toxicity of kidney transplant immunosuppression.
    2009 | PubMed
  169. Deconvoluting the 'omics' for organ transplantation.
    2009 | PubMed
  170. Promotion of altruistic donation.
    2009 | PubMed
  171. Long-term outcome following pediatric liver transplantation for metabolic disorders.
    2009 | PubMed
  172. Steroid-free immunosuppression in pediatric renal transplantation: rationale for and [corrected] outcomes following conversion to steroid based therapy.
    2009 | PubMed
  173. C3 polymorphisms and outcomes of renal allografts.
    2009 | PubMed
  174. Expression of complement components differs between kidney allografts from living and deceased donors.
    2009 | PubMed
  175. Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.
    2009 | PubMed
  176. Standardizing resistive indices in healthy pediatric transplant recipients of adult-sized kidneys.
    2009 | PubMed
  177. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures.
    2009 | PubMed
  178. Calcineurin inhibitor nephrotoxicity.
    2009 | PubMed
  179. Using gene arrays in diagnosis of rejection.
    2009 | PubMed
  180. Interpreting the proteome and peptidome in transplantation.
    2009 | PubMed
  181. Combined liver-kidney transplantation in children: indications and outcome.
    2008 | PubMed
  182. A critical look at the immunologically favorable adult-sized kidney transplant in small children.
    2008 | PubMed
  183. Extended daclizumab monotherapy for rejection-free survival in non-adherent adolescent recipients of renal allografts.
    2008 | PubMed
  184. Out with the old, in with the new: immunosuppression minimization in children.
    2008 | PubMed
  185. A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.
    2008 | PubMed
  186. Microarrays: monitoring for transplant tolerance and mechanistic insights.
    2008 | PubMed
  187. The proteogenomic path towards biomarker discovery.
    2008 | PubMed
  188. Renal transplantation in children with thrombosis of the inferior vena cava requires careful assessment and planning.
    2008 | PubMed
  189. Patient selection critical for calcineurin inhibitor withdrawal in pediatric kidney transplantation.
    2008 | PubMed
  190. "To B or not to B?" B-cells and graft rejection.
    2008 | PubMed
  191. In praise of arrays.
    2008 | PubMed
  192. Characterization of intra-graft B cells during renal allograft rejection.
    2008 | PubMed
  193. Optimizing protein recovery for urinary proteomics, a tool to monitor renal transplantation.
    2008 | PubMed
  194. Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients.
    2008 | PubMed
  195. Looking into the crystal chip: can microarrays predict graft function?
    2008 | PubMed
  196. Liposomal amphotericin B associated with severe hyperphosphatemia.
    2008 | PubMed
  197. Potential influence of tacrolimus and steroid avoidance on early graft function in pediatric renal transplantation.
    2007 | PubMed
  198. Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples.
    2007 | PubMed
  199. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance.
    2007 | PubMed
  200. Transplant reno-vascular stenoses associated with early erythropoietin use.
    2007 | PubMed
  201. The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients.
    2007 | PubMed
  202. Immunosuppression minimization in pediatric transplantation.
    2007 | PubMed
  203. Optimizing outcomes for neonatal ARPKD.
    2007 | PubMed
  204. Sirolimus is not always responsible for new-onset proteinuria after conversion for chronic allograft nephropathy.
    2007 | PubMed
  205. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation.
    2007 | PubMed
  206. Proteinuria in pediatric renal transplant recipients during the first 60 post-transplant days.
    2006 | PubMed
  207. Designer genes: Filling the gap in transplantation.
    2006 | PubMed
  208. Successful renal transplantation in high-risk small children with a completely thrombosed inferior vena cava.
    2006 | PubMed
  209. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies.
    2006 | PubMed
  210. Microarrays: a monitoring tool for transplant patients?
    2006 | PubMed
  211. Chipping into the human genome: novel insights for transplantation.
    2006 | PubMed
  212. Option of pre-emptive nephrectomy and renal transplantation for Bartter's syndrome.
    2006 | PubMed
  213. Three cases of suspected antibody-mediated rejection.
    2006 | PubMed
  214. Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profiling.
    2005 | PubMed
  215. Steroid elimination is coming of age.
    2005 | PubMed
  216. Mycophenolate mofetil in pediatric renal transplantation.
    2005 | PubMed
  217. Expression profiling of murine double-negative regulatory T cells suggest mechanisms for prolonged cardiac allograft survival.
    2005 | PubMed
  218. Corticosteroid avoidance in pediatric renal transplantation.
    2005 | PubMed
  219. Gastrointestinal leukocytoclastic vasculitis: an adverse effect of sirolimus.
    2005 | PubMed
  220. Vulnerability of small pediatric recipients to laparoscopic living donor kidneys.
    2005 | PubMed
  221. First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future.
    2005 | PubMed
  222. Management of methylmalonic acidaemia by combined liver-kidney transplantation.
    2005 | PubMed
  223. Correlation between gene expression and morphological alterations in baboon carotid after balloon dilatation injury.
    2004 | PubMed
  224. Microangiopathy of brain, retina, and inner ear (Susac's syndrome) in an adolescent female presenting as acute disseminated encephalomyelitis.
    2004 | PubMed
  225. Arraying the orchestration of allograft pathology.
    2004 | PubMed
  226. Corticosteroid avoidance in pediatric renal transplantation: can it be achieved?
    2004 | PubMed
  227. Microarrays: interrogating the transplant transcriptosome.
    2004 | PubMed
  228. Noncirrhotic portal hypertension in association with juvenile nephropathic cystinosis: case presentation and review of the literature.
    2004 | PubMed
  229. Postdialysis albumin: a better nutrition marker in pediatric hemodialysis patients?
    2004 | PubMed
  230. A typology of non-adherence in pediatric renal transplant recipients.
    2003 | PubMed
  231. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience.
    2003 | PubMed
  232. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
    2003 | PubMed
  233. Applications of microarrays to renal transplantation: progress and possibilities.
    2003 | PubMed
  234. Safety and risk stratification of percutaneous biopsies of adult-sized renal allografts in infant and older pediatric recipients.
    2003 | PubMed
  235. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.
    2003 | PubMed
  236. Chronic rejection: prospects for therapeutic intervention in fibroproliferative vascular disease.
    2003 | PubMed
  237. Microarrays: new tools for transplantation research.
    2003 | PubMed
  238. Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression.
    2003 | PubMed
  239. Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays.
    2003 | PubMed
  240. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients.
    2002 | PubMed
  241. Limited surgical interventions in children with posterior urethral valves can lead to better outcomes following renal transplantation.
    2002 | PubMed
  242. Rational drug design: making drugs that make a difference.
    2002 | PubMed
  243. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation.
    2001 | PubMed
  244. Visual loss caused by pseudotumor cerebri in an infant on peritoneal dialysis.
    2001 | PubMed
  245. Genomic analysis of renal allograft dysfunction using cDNA microarrays.
    2001 | PubMed
  246. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation.
    2001 | PubMed
  247. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    2000 | PubMed
  248. Sodium ferric gluconate therapy in renal transplant and renal failure patients.
    2000 | PubMed
  249. A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts.
    2000 | PubMed
  250. Renal perfusion in infant recipients of adult-sized kidneys is a critical risk factor.
    2000 | PubMed
  251. Pulmonary capillary leak syndrome with intravenous cyclosporin A in pediatric renal transplantation.
    2000 | PubMed
  252. A new, unique and simple method for ureteral implantation in kidney recipients with small, defunctionalized bladders.
    1999 | PubMed
  253. Transplantation of adult-sized kidneys into infants induces major blood flow changes.
    1999 | PubMed
  254. Successful transplantation of adult-sized kidneys into infants requires maintenance of high aortic blood flow.
    1998 | PubMed
  255. G protein alpha subunit multigene family in the Japanese puffer fish Fugu rubripes: PCR from a compact vertebrate genome.
    1996 | PubMed
  256. Nepal Family Cohort study: a study protocol.
    2024 | PubMed
  257. Gene expression-based molecular scoring of pancreas transplant rejection for a quantitative assessment of rejection severity and resistance to treatment.
    2024 | PubMed
  258. Proteome Analysis for Inflammation Related to Acute and Convalescent Infection.
    2023 | PubMed
  259. Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection.
    2023 | PubMed
  260. Plasma proteome perturbation for CMV DNAemia in kidney transplantation.
    2023 | PubMed
  261. Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors.
    2023 | PubMed
  262. Longitudinal serum proteomics analyses identify unique and overlapping host response pathways in Lyme disease and West Nile virus infection.
    2022 | PubMed
  263. Perturbations of the T-cell immune repertoire in kidney transplant rejection.
    2022 | PubMed
  264. A reference tissue atlas for the human kidney.
    2022 | PubMed
  265. Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.
    2022 | PubMed
  266. Multiplexed droplet single-cell sequencing (Mux-Seq) of normal and transplant kidney.
    2021 | PubMed
  267. FcER1: A Novel Molecule Implicated in the Progression of Human Diabetic Kidney Disease.
    2021 | PubMed
  268. A Comprehensive Urine Proteome Database Generated From Patients With Various Renal Conditions and Prostate Cancer.
    2021 | PubMed
  269. Use of the Tissue Common Rejection Module Score in Kidney Transplant as an Objective Measure of Allograft Inflammation.
    2021 | PubMed
  270. Corrigendum: Near-Single-Cell Proteomics Profiling of the Proximal Tubular and Glomerulus of the Normal Human Kidney.
    2021 | PubMed
  271. A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project.
    2020 | PubMed
  272. Near-Single-Cell Proteomics Profiling of the Proximal Tubular and Glomerulus of the Normal Human Kidney.
    2020 | PubMed
  273. Peripheral Blood RNA Sequencing Unravels a Differential Signature of Coding and Noncoding Genes by Types of Kidney Allograft Rejection.
    2020 | PubMed
  274. Targeted Urine Metabolomics for Monitoring Renal Allograft Injury and Immunosuppression in Pediatric Patients.
    2020 | PubMed
  275. Avoidance of CNI and steroids using belatacept-Results of the Clinical Trials in Organ Transplantation 16 trial.
    2020 | PubMed
  276. A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection.
    2020 | PubMed
  277. Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies.
    2019 | PubMed
  278. A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring.
    2019 | PubMed
  279. A Modified Injector and Sample Acquisition Protocol Can Improve Data Quality and Reduce Inter-Instrument Variability of the Helios Mass Cytometer.
    2019 | PubMed
  280. Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.
    2019 | PubMed
  281. A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury.
    2019 | PubMed
  282. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.
    2019 | PubMed
  283. Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR.
    2018 | PubMed
  284. The common rejection module in chronic rejection post lung transplantation.
    2018 | PubMed
  285. Urinary Virome Perturbations in Kidney Transplantation.
    2018 | PubMed
  286. Targeted Transcriptional Profiling of Kidney Transplant Biopsies.
    2018 | PubMed
  287. Corrigendum: Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant.
    2018 | PubMed
  288. Discovery of Immune Reactive Human Proteins by High-Density Protein Arrays and Customized Validation of Potential Biomarkers by ELISA.
    2018 | PubMed
  289. Fractionation of Soluble Proteins Using DEAE-Sepharose, SP-Sepharose, and Phenyl Sepharose Chromatographies for Proteomics.
    2018 | PubMed
  290. LC-SRM-Based Targeted Quantification of Urinary Protein Biomarkers.
    2018 | PubMed
  291. Optimization for Peptide Sample Preparation for Urine Peptidomics.
    2018 | PubMed
  292. Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant.
    2017 | PubMed
  293. Expression of Mitochondrial-Encoded Genes in Blood Differentiate Acute Renal Allograft Rejection.
    2017 | PubMed
  294. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.
    2017 | PubMed
  295. Assessment of Circulating Protein Signatures for Kidney Transplantation in Pediatric Recipients.
    2017 | PubMed
  296. Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
    2017 | PubMed
  297. Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes.
    2017 | PubMed
  298. A combined biomarker and clinical panel for chronic graft versus host disease diagnosis.
    2016 | PubMed
  299. Advances in diagnostics for transplant rejection.
    2016 | PubMed
  300. Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated Nephropathy.
    2016 | PubMed
  301. Self-antigens and rejection: a proteomic analysis.
    2016 | PubMed
  302. Mining the human urine proteome for monitoring renal transplant injury.
    2016 | PubMed
  303. Circulating CD40 autoantibody and suPAR synergy drives glomerular injury.
    2015 | PubMed
  304. A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts.
    2015 | PubMed
  305. Transcriptional Perturbations in Graft Rejection.
    2015 | PubMed
  306. Perturbations in the urinary exosome in transplant rejection.
    2015 | PubMed
  307. Mapping novel immunogenic epitopes in IgA nephropathy.
    2014 | PubMed
  308. A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation.
    2014 | PubMed
  309. The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.
    2014 | PubMed
  310. Endothelial cell antibodies associated with novel targets and increased rejection.
    2014 | PubMed
  311. A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.
    2014 | PubMed
  312. Optimization for peptide sample preparation for urine peptidomics.
    2014 | PubMed
  313. Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection.
    2013 | PubMed
  314. The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics.
    2013 | PubMed
  315. Moving beyond HLA: a review of nHLA antibodies in organ transplantation.
    2013 | PubMed
  316. A rapid noninvasive assay for the detection of renal transplant injury.
    2013 | PubMed
  317. Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling.
    2013 | PubMed
  318. Immune response profiling identifies autoantibodies specific to Moyamoya patients.
    2013 | PubMed
  319. The clinical impact of humoral immunity in pediatric renal transplantation.
    2013 | PubMed
  320. A common blood gene assay predates clinical and histological rejection in kidney and heart allografts.
    2013 | PubMed
  321. Discovery and customized validation of antibody targets by protein arrays and indirect ELISA.
    2013 | PubMed
  322. A peripheral blood diagnostic test for acute rejection in renal transplantation.
    2012 | PubMed
  323. Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up.
    2012 | PubMed
  324. Protein and peptide biomarkers in organ transplantation.
    2012 | PubMed
  325. Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury.
    2012 | PubMed
  326. Cell-free DNA as a measure of transplant injury.
    2012 | PubMed
  327. Characterization of Zn(II)-responsive ribosomal proteins YkgM and L31 in E. coli.
    2011 | PubMed
  328. Profiling of autoantibodies in IgA nephropathy, an integrative antibiomics approach.
    2011 | PubMed
  329. Recent advances in biomarker discovery in solid organ transplant by proteomics.
    2011 | PubMed
  330. The dual role of epithelial-to-mesenchymal transition in chronic allograft injury in pediatric renal transplantation.
    2011 | PubMed
  331. Functional proteogenomics--embracing complexity.
    2011 | PubMed
  332. Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes.
    2011 | PubMed
  333. Profiling the proteome in renal transplantation.
    2011 | PubMed
  334. Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease.
    2010 | PubMed
  335. Differential immunogenicity and clinical relevance of kidney compartment specific antigens after renal transplantation.
    2010 | PubMed
  336. Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions.
    2010 | PubMed
  337. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation.
    2010 | PubMed
  338. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection.
    2010 | PubMed
  339. Shotgun proteomics identifies proteins specific for acute renal transplant rejection.
    2010 | PubMed
  340. Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients.
    2009 | PubMed
  341. Expression of complement components differs between kidney allografts from living and deceased donors.
    2009 | PubMed
  342. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures.
    2009 | PubMed
  343. Interpreting the proteome and peptidome in transplantation.
    2009 | PubMed
  344. A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.
    2008 | PubMed
  345. The proteogenomic path towards biomarker discovery.
    2008 | PubMed
  346. Optimizing protein recovery for urinary proteomics, a tool to monitor renal transplantation.
    2008 | PubMed
  347. Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples.
    2007 | PubMed
  348. Probing the adaptive response of Escherichia coli to extracellular Zn(II).
    2006 | PubMed
  349. Transcriptional response of Escherichia coli to TPEN.
    2006 | PubMed
  350. Phosphinate, sulfonate, and sulfonamidate dipeptides as potential inhibitors of Escherichia coli aminopeptidase N.
    2005 | PubMed
  351. A five-coordinate metal center in Co(II)-substituted VanX.
    2005 | PubMed
  352. Fractionation of soluble proteins in Escherichia coli using DEAE-, SP-, and phenyl sepharose chromatographies.
    2004 | PubMed
  353. L-alanine-p-nitroanilide is not a substrate for VanX.
    2004 | PubMed
  354. Over-expression, purification, and characterization of metallo-beta-lactamase ImiS from Aeromonas veronii bv. sobria.
    2004 | PubMed
  355. In vivo folding of recombinant metallo-beta-lactamase L1 requires the presence of Zn(II).
    2004 | PubMed